Journals / Turkish Neurosurgery / 2016 / Cilt: 26 - Sayı: 1

Protective Effect of Ad-VEGF-Bone Mesenchymal Stem Cells on Cerebral Infarction

Pages
8–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

COnCluSIOn: Our findings demonstrate that PI3K/AKT/GSK3? pathway could reduce reactive gliosis, ameliorate neurological deficit, diminish the percentage of cerebral infarction volume in rats, and facilitate angiogenesis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To understand the mechanism of intracerebroventricular transplantation of vascular endothelial growth factor (VEGF) genemodified bone mesenchymal stem cells (BMSCs) in rats after cerebral infarction.
📊
Key Findings & Data:The rats were divided into 3 groups.
💡
Conclusion & Impact:COnCluSIOn: Our findings demonstrate that PI3K/AKT/GSK3? pathway could reduce reactive gliosis, ameliorate neurological deficit, diminish the percentage of cerebral infarction volume in rats, and facilitate angiogenesis
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

AIM: To understand the mechanism of intracerebroventricular transplantation of vascular endothelial growth factor (VEGF) genemodified bone mesenchymal stem cells (BMSCs) in rats after cerebral infarction. MATERIAl and METhODS: The middle cerebral artery occlusion ischemia/reperfusion (MCAO I/R) model was established in rats using the Zea-Longa suture method. A recombinant adenovirus (Ad-VEGF) was engineered to express VEGF. The rats were divided into 3 groups. Control BMSC infected with control adenovirus (BMSC-Ad), BMSC infected by Ad-VEGF (BMSC-Ad-VEGF), and phosphate buffered saline (PBS) suspension were injected into the intracerebroventricular system of the rats in groups 1, 2 and 3 respectively, 24 hours after middle cerebral artery occlusion (MCAO). The neurological function of rats was evaluated with the modified Neurological Severity Scores (mNSS). The infarct volume of brain in rats was determined using 2,3,5-triphenyltetrazolium chloride (TTC) stain at 14 days. GFAP and pGSK3? expression of ischemic penumbra was determined using immunohistochemical method. GFAP, pAKT, AKT, and pGSK3? expressions were determined with Western blot. RESulTS: Functional improvement was accelerated in animals receiving BMSC-Ad, while improvement at all times between 7 days and 28 days post MCAO was significantly greater in animals transplanted with BMSC-Ad-VEGF than for other treated animals. The number of GFAP-labeled cells was prevented by post-ischemic BMSC-Ad-VEGF treatment; pMCAO activate the PI3K/AKT/GSK3? pathway to reduce reactive gliosis. COnCluSIOn: Our findings demonstrate that PI3K/AKT/GSK3? pathway could reduce reactive gliosis, ameliorate neurological deficit, diminish the percentage of cerebral infarction volume in rats, and facilitate angiogenesis

🔖

Cite This Article

CHEN, B., ZHANG, F., LI, Q., GONG, A., LAN, Q. (2016). Protective Effect of Ad-VEGF-Bone Mesenchymal Stem Cells on Cerebral Infarction. Turkish Neurosurgery, Cilt: 26 - Sayı: 1, 8–15. https://ajindex.com/articles/405403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. araujo M, Wandosell F: Differential cellular response after glutamate analog hippocampus damage. J Neurosci Res 44: 397 - 409, 1996
  2. Benakis C, Bonny C, Hirt L: JNK inhibition and inflammation after cerebral ischemia. Brain Behav Immun 24:800-811, 2010
  3. Bovolenta P, Wandosell F, Nieto-Sampedro M: CNS glial scar tissue: A source of molecules which inhibit central neurite outgrowth. prog Brain Res 94:367 - 379, 1992
  4. Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M: Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189:49-57, 2001
  5. Chiba Y, Sasayama T, Miyake S, Koyama J, Kondoh T, Hosoda K, Kohmura E: Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe J Med Sci 54:E136-146, 2008
  6. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989
  7. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J: Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 264:20017-20024, 1989
  8. Endo H, Nito C, Kamada H, Nishi T, Chan PH: Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 26:1479 - 1489, 2006
  9. Gao X, Zhang H, Takahashi T, Hsieh J, Liao J, Steinberg GK, Zhao H: The Akt signaling pathway contributes to postconditioning's protection against stroke; The protection is associated with the MAPK and PKC pathways. J Neurochem 105:943-955, 2008 graham gD: Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. stroke 34: 2847-2850, 2003
  10. Sun B, Chen L, Wei X, Xiang Y, Liu X, Zhang X: The Akt/GSK- 3beta pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats. Biochem Biophys Res Comm 409: 808 - 813, 2011
  11. Towfighi A, Ovbiagele B, Saver JL: Therapeutic mile-stone: Stroke declines from the second to the third leading organ- and disease- specific cause of death in the United States. Stroke 41:499-503, 2009
  12. Wang H, Wang g, Yu Y, Wang Y: The role of phosphoinositide-3- kinase /akt pathway in propofol-induced postconditioning against focal cerebral ischemia -reperfusion injury in rats. Brain Res 1297: 177-